Bilthoven Biologicals
Erik Oevering-Ciobanu has a diverse work experience spanning over 20 years. Their most recent position was at Bilthoven Biologicals, where they held the roles of Head Operator DSP and Head Operator USP. Erik started in May 2017 as a Senior Operator B before being promoted to the head roles. Prior to that, they worked at Merial as a Process Operator from December 2013 to May 2017. Erik also gained experience as a Timmerman at both HalDu Groep and J.P. van Eesteren |TBI, starting in 2012 and 2000 respectively.
Erik Oevering-Ciobanu's education history includes the following:
From 2023 to 2024, Erik studied the Romanian language at NHA Distance Learning in Panningen, Holland.
Between 2014 and 2016, Erik pursued a pharmacy technician program called "edufarma farmaceutisch technicus."
In 2011, Erik completed a course in VCA-VOL at VCA Nederland.
From 2005 to 2008, Erik studied "ass. uitvoerder b & u bol 4" at Deltion College Zwolle.
In 2003, Erik attended ROC Flevoland and focused on voortgezet timmeren.
From 2000 to 2002, Erik studied primair timmeren at ROC Flevoland.
In 1992, Erik attended Chr. Hogeschool Windesheim and pursued HSAO p & o.
Between 1989 and 1992, Erik completed a commercial program at Meao Emmeloord.
From 1984 to 1989, Erik attended Bonifatius Mavo Emmeloord and studied mavo d.
In 2022, Erik enrolled at NTI and is currently pursuing a Bachelor of Applied Science (BASc) degree in Marketing/Commerciële economie (CE) with a specialization in marketing management.
This person is not in any offices
Bilthoven Biologicals
About Bilthoven Biologicals Bilthoven Biologicals is a biopharmaceutical company which produces Inactivated Polio Vaccines (IPV), Tetanus Vaccines, Diphtheria-Tetanus-Polio Vaccines (DT-PV) and Bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer. We deliver our vaccines to UNICEF, with which we support the World Health Organisation (WHO) to eradicate polio. Bilthoven Biologicals has been part of the Cyrus Poonawalla Group since 2012, the world’s largest vaccine producer and employs more than 500 employees. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/en/what-we-produce/report-side-effects/ Over Bilthoven Biologicals Bilthoven Biologicals is een biofarmaceutisch bedrijf dat geïnactiveerde polio vaccins (IPV), Tetanus vaccins, Difterie-Tetanus-Polio vaccins (DT-IPV) produceert en Bacillus Calmette-Guérin (BCG) voor de behandeling van blaaskanker. Wij leveren onze vaccins aan UNICEF, waarmee wij de Wereldgezondheidsorganisatie (WHO) ondersteunen bij het uitroeien van polio. Bilthoven Biologicals is sinds 2012 onderdeel van de Cyrus Poonawalla Group, de grootste vaccinproducent ter wereld en heeft ruim 500 medewerkers. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/wat-wij-maken/bijwerkingen-melden/